Category: Regulatory/FDA

Next OPDP Webinar Will Address Five Months of Enforcement Actions

Kamp Commentary: Supreme Court Decision Could End “Pay for Delay”

Promotion Down, But Prospects Up for New Drugs

“Cyberspace Is Not Without Boundaries,” FTC States in Digital Advertising Guidelines

OPDP Restructuring Divisions To Provide “Close Oversight” of DTC Advertising

Coalition’s Policy Update: Keep Fiscal Challenges, Privacy Regulation on Radar

FDA Responds to Comments on Proposed Corrective DTC Advertising Study

OPDP Untitled Letters on PR Materials Surprise Industry

AMA To Align CME Guidance with ACCME Standards